1Baker EN,Baker HM.Molecular structure,binding properties and dynamics of lactoferrin.Cell Mol Life Sci,2005,62:2531-2539.
2Lupetti A,Paulusma-Annema A,Welling MM,et al.Candidacidal activities of human lactoferrin peptides derived from the N terminus.Antimicrob Agents Chemother,2000,44:3257-3263.
3Valenti P,Antonini G.Lactoferrin:an important host defence against microbial and viral attack.Cell.Mol.Life Sci,2005,62:2576-2587.
4Gifford JL,Hunter HN,Vogel HJ.Lactoferricin:a lactoferrinderived peptide with antimicrobial,antiviral,antitumor and immunological properties.Cell Mol Life Sci,2005,62:2588-2598.
5Anderson JH,Jenssen H,Gutteberg TJ.Lactoferrin and lactoferricin inhibit Herpes simplexs 1 and 2 infection and exhibit synergy when combined with acyclovir.Antiviral Res,2003,1796:127.
6McCann KB,Lee A,Wan J,et al.The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate)and poliovirus to infect cell cultures.J Appl microbiol.2003,95:1026-1033.
7Andersen JH,Osbakk SA,Vorland LH,et al.Lactoferrin and cyclic lactoferricin inhibit the entry of humancytomegalovirus into human fibrohlasts.Antiviral Res,2001,51:141-149.
8Van der Strate BW,Harmsen MC,Schafer P,et al.Viral load in breast milk conelates with transmission of human cytomegalovirus to preterm neonates,but lactoferrin concentrations do not.Clin Diagn Lab Immunol,2001,8:818-821.
9Beljaars L,van der Strate BW,Bakker HI,et al.Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo.Antiviral Res.2004,63:197-208.
10Beljaars L,Bakker HI,Van der Strate BW,et al.The antiviral protein human lactoferrin is distributed in the body to cytomegalovirus (CMV) infection-prone cells and tissues.Pharm Res,2002,19:54-62.
